Liu Y, Wang F, Zhang QC, Tong ZH. Value of virtual bronchoscopic navigation and transbronchial ultrasound-guided sheath-guided exploration in diagnosis of peripheral lung cancer. World J Clin Cases 2020; 8(16): 3450-3457 [PMID: 32913851 DOI: 10.12998/wjcc.v8.i16.3450]
Corresponding Author of This Article
Zhao-Hui Tong, MD, PhD, Chief Physician, Department of Respiratory and Critical Care Medicine, Beijing Chaoyang Hospital, Capital Medical University; Beijing Institute of Respiratory Medicine, No. 8 South Gongti Road, Chaoyang District, Beijing 100020, China. 13910930309@163.com
Research Domain of This Article
Oncology
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Yong Liu, Feng Wang, Zhao-Hui Tong, Department of Respiratory and Critical Care Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
Yong Liu, Department of Respiratory and Critical Care Medicine, Zhoukou Central Hospital, Zhoukou 466100, Henan Province, China
Feng Wang, Zhao-Hui Tong, Beijing Institute of Respiratory Medicine, Beijing 100020, China
Qun-Cheng Zhang, Department of Respiratory and Critical Care Medicine, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Zhengzhou 450003, Henan Province, China
Author contributions: Liu Y, Wang F, and Tong ZH performed the operation; Zhang QC designed this retrospective study; Liu Y wrote the paper; Wang F was responsible for sorting the data.
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of the Zhoukou Central Hospital.
Informed consent statement: Informed consent was obtained from the patients.
Conflict-of-interest statement: Dr. Tong reports grants from Beijing Municipal Science and Technology Commission (No. Z181100001718185) during the conduct of the study.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Zhao-Hui Tong, MD, PhD, Chief Physician, Department of Respiratory and Critical Care Medicine, Beijing Chaoyang Hospital, Capital Medical University; Beijing Institute of Respiratory Medicine, No. 8 South Gongti Road, Chaoyang District, Beijing 100020, China. 13910930309@163.com
Received: May 10, 2020 Peer-review started: May 10, 2020 First decision: June 7, 2020 Revised: June 20, 2020 Accepted: July 14, 2020 Article in press: July 14, 2020 Published online: August 26, 2020 Processing time: 106 Days and 21.9 Hours
ARTICLE HIGHLIGHTS
Research background
Early peripheral lung cancer has no significant symptoms, and when the symptoms are obvious, the cancer is in a late stage.
Research motivation
It is necessary to have a clear molecular diagnosis based on different targets to initiate individualized treatment and promote a therapeutic effect.
Research objectives
To explore a new technique in the diagnosis of peripheral lung cancer.
Research methods
Patients in the control group underwent transbronchial ultrasound-guided sheath-guided (EBUS-GS) exploration, and the observation group received virtual bronchoscopic navigation (VBN) in combination with EBUS-GS exploration.
Research results
There were no significant differences in diagnosis rate or total operation time between the two groups (P > 0.05), and the time needed to determine the lesion in the observation group was less than that of the control group (P < 0.05).
Research conclusions
The combined use of VBN and EBUS-GS exploration technology has little effect on the diagnostic rate and total operating time in peripheral lung cancer.
Research perspectives
The new technology provides a new idea for the early diagnosis of lung cancer.
